We chose two distinct models to test our hypothesis: 1) the leptin receptor deficient mouse (dbdb) model of diabetic polyneuropathy and 2) superoxide dismutase 1 knockout (Sod1−/−) mouse model of in vivo oxidative stress. This evidence concerns the gene LEPR and diabetic polyneuropathy.